BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3376114)

  • 1. Effect of alteration of nerve terminal Ca2+ regulation on increased spontaneous quantal release of acetylcholine by methyl mercury.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):55-65. PubMed ID: 3376114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of mitochondrial inhibitors with methylmercury on spontaneous quantal release of acetylcholine.
    Levesque PC; Atchison WD
    Toxicol Appl Pharmacol; 1987 Feb; 87(2):315-24. PubMed ID: 2435022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylmercury-induced depression of neuromuscular transmission in the rat.
    Atchison WD; Narahashi T
    Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of mitochondrial Ca2+ release diminishes the effectiveness of methyl mercury to release acetylcholine from synaptosomes.
    Levesque PC; Hare MF; Atchison WD
    Toxicol Appl Pharmacol; 1992 Jul; 115(1):11-20. PubMed ID: 1378659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular calcium-dependent and -independent effects of methylmercury on spontaneous and potassium-evoked release of acetylcholine at the neuromuscular junction.
    Atchison WD
    J Pharmacol Exp Ther; 1986 May; 237(2):672-80. PubMed ID: 3084765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of activation of sodium and calcium entry on spontaneous release of acetylcholine induced by methylmercury.
    Atchison WD
    J Pharmacol Exp Ther; 1987 Apr; 241(1):131-9. PubMed ID: 2437285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of action of lead on neuromuscular junctions.
    Atchison WD; Narahashi T
    Neurotoxicology; 1984; 5(3):267-82. PubMed ID: 6097847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maitotoxin activates quantal transmitter release at the neuromuscular junction: evidence for elevated intraterminal Ca2+ in the motor nerve terminal.
    Kim YI; Login IS; Yasumoto T
    Brain Res; 1985 Nov; 346(2):357-62. PubMed ID: 2996708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement by Anemonia sulcata toxin II of spontaneous quantal transmitter release from mammalian motor nerve terminals.
    Molgo J; Lemeignan M; Tazieff-Depierre F
    Toxicon; 1986; 24(5):441-50. PubMed ID: 2872736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iberiotoxin-induced block of Ca2+-activated K+ channels induces dihydropyridine sensitivity of ACh release from mammalian motor nerve terminals.
    Flink MT; Atchison WD
    J Pharmacol Exp Ther; 2003 May; 305(2):646-52. PubMed ID: 12606686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of quantal secretion induced by ouabain and its correlation with depletion of synaptic vesicles.
    Haimann C; Torri-Tarelli F; Fesce R; Ceccarelli B
    J Cell Biol; 1985 Nov; 101(5 Pt 1):1953-65. PubMed ID: 3932368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of methylmercury-induced block of nerve-evoked release of acetylcholine at the neuromuscular junction.
    Traxinger DL; Atchison WD
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):23-33. PubMed ID: 3629589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydropyridine-sensitive and -insensitive components of acetylcholine release from rat motor nerve terminals.
    Atchison WD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):672-8. PubMed ID: 2478694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of divalent cations on the methylmercury-induced alterations of acetylcholine release.
    Traxinger DL; Atchison WD
    J Pharmacol Exp Ther; 1987 Feb; 240(2):451-9. PubMed ID: 3027312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in acetylcholine concentration, miniature end-plate potentials and synaptic vesicles in frog neuromuscular preparations during lanthanum treatment.
    Florey E; Kriebel ME
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1983; 75(2):285-94. PubMed ID: 6138197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lead on neuromuscular transmission in the frog.
    Manalis RS; Cooper GP; Pomeroy SL
    Brain Res; 1984 Feb; 294(1):95-109. PubMed ID: 6320979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Ca(2+)-dependent and Ca(2+)-independent miniature endplate potentials by phorbol ester and adenosine in frog.
    Searl TJ; Silinsky EM
    Br J Pharmacol; 2005 Aug; 145(7):954-62. PubMed ID: 15880138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of an L-type Ca2+ channel antagonist on activity- and phosphorylation-enhanced release of acetylcholine at the neuromuscular junction of the frog in vitro.
    Arenson MS; Gill DS
    Eur J Neurosci; 1996 Mar; 8(3):437-45. PubMed ID: 8963434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The thiol-oxidizing agent diamide increases transmitter release by decreasing calcium requirements for neuromuscular transmission in the frog.
    Carlen PL; Kosower EM; Werman R
    Brain Res; 1976 Nov; 117(2):257-76. PubMed ID: 186154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-dependent actions of the convulsant barbiturate, CHEB, on transmitter release at the rat neuromuscular junction.
    Nicholson GM; Spence I; Johnston GA
    Gen Pharmacol; 1990; 21(5):741-6. PubMed ID: 1980474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.